Danish IT Stock News

As the European markets face pressures from concerns over artificial intelligence stock valuations, major indices like the STOXX Europe 600 and Germany's DAX have recently seen declines. In this environment, investors may find opportunities in value stocks that are trading at estimated discounts, offering potential resilience amidst market fluctuations.

The market rallied behind Trifork Group AG's ( CPH:TRIFOR ) stock, leading do a rise in the share price after its...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

As European markets face a pullback amid concerns over artificial intelligence stock valuations, major indices like the STOXX Europe 600 and Germany's DAX have seen declines. In this environment of cautious sentiment, identifying undervalued stocks can provide opportunities for investors seeking potential value plays.

Most people feel a little frustrated if a stock they own goes down in price. But sometimes broader market conditions...

It's been a mediocre week for GN Store Nord A/S ( CPH:GN ) shareholders, with the stock dropping 10% to kr.102 in the...

Shareholders might have noticed that Solar A/S ( CPH:SOLAR B ) filed its quarterly result this time last week. The...

A.P. Møller - Mærsk A/S ( CPH:MAERSK B ) just released its latest third-quarter results and things are looking bullish...

Key Insights Given the large stake in the stock by institutions, DSV's stock price might be vulnerable to their trading...

Coloplast (CPSE:COLO B) is projecting healthy momentum, with earnings forecast to grow at 15.8% per year, outpacing the Danish market's 3.7% average. Revenue is also expected to climb at 6.9% annually, ahead of the market's 5% rate. Despite these positive forecasts, the company’s net profit margin has contracted to 13% from 18.7% last year. Five-year earnings growth has averaged just 0.03% per year, with earnings declining over the past year. Investors are eyeing Coloplast’s above-market...

Wondering if Bavarian Nordic is a hidden gem or simply riding the latest biotech wave? Let's dig in and see if the stock is living up to its reputation. Bavarian Nordic shares have seen a solid 18.2% jump year-to-date and are up 13.6% over the past year, but there was a slight dip of 0.6% just last week. Recent headlines highlight the company's expanding role in vaccine development, with positive investor sentiment driven by new partnerships and regulatory milestones. These developments have...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...

Wondering if Danske Bank is a hidden gem or already priced to perfection? Let's dig into what the numbers and recent market action are signaling about its current value. Danske Bank’s stock has been on a tear, surging 6.3% in the past week and up 42.0% year-to-date, with an impressive 52.7% gain over the last 12 months. Recent news highlights Danske Bank’s ongoing digital transformation and several strategic partnerships, both of which have caught investor attention. Industry talk about...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

The Netcompany Group A/S ( CPH:NETC ) share price has done very well over the last month, posting an excellent gain of...

With a price-to-earnings (or "P/E") ratio of 13.2x H. Lundbeck A/S ( CPH:HLUN B ) may be sending bullish signals at the...

Per Aarsleff Holding (CPH:PAAL B) has had a great run on the share market with its stock up by a significant 14% over...

Key Insights The projected fair value for TORM is kr.225 based on 2 Stage Free Cash Flow to Equity TORM's kr.139 share...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Embla Medical hf (CPSE:EMBLA) posted earnings forecast to grow at 14.51% per year, with revenue set to rise by 8.5% annually. Both figures are ahead of the Danish market’s expected growth. The company’s net profit margin edged up to 8.6% from 8.2% the year before. While the most recent year’s earnings growth came in at 11.7%, the broader five-year average sits at a robust 19.2% per year. Embla’s combination of faster-than-market growth and steadily improving profitability, coupled with a lack...

Key Insights Significant control over FLSmidth by retail investors implies that the general public has more power to...

GN Store Nord A/S ( CPH:GN ), might not be a large cap stock, but it received a lot of attention from a substantial...